7/26/2025Ambroxol Hydrochloride Drops Reclassified as OTC Drug in China

7/26/2025China's Basic Medical Insurance Fund Reports Surplus in H1/2025

7/26/2025Recent Official and Executive Moves

7/26/2025China's Sciwind in Licensing Talks to Bring Weight-Loss Drug to U.S. M...

7/26/2025China Leads Global Expansion in Clinical Trial Volume in Q2 2025: Glob...

7/25/2025China Launches Nationwide Pilot Program for Smart Medical Insurance Ov...

7/25/2025Everest Secures $200M in Share Placement while Epirium Bio Prepares $5...

7/25/2025AusperBio Advances AHB‑137 to Phase 3 After Green Light from China NM...

7/25/2025Eisai's Lenvatinib Secures NMPA Approval in China

7/25/2025Yangtze River Pharma's Tunodafil Wins NMPA Nod

7/25/2025Newish Secures Series B1 Investment to Propel Nucleic Acid Cancer Vac...

7/24/2025Zonsen PepLib Biotech Closes ~CNY 100M Series B Round

7/24/2025Cascade Pharma's CS0159 Wins FDA Breakthrough For PBC

7/24/2025Kelun-Biotech Initiates Phase I Trial of SKB107

7/24/2025Pfizer Finalizes 3SBio Deal, Prepares Global Phase 3 Launch for BsAb S...

7/24/2025Roche Sees Strong China Pharma Growth in H12025

7/23/2025Kelun‑Biotech Launches Phase I Trial of SKB107 in China to Tackle Bon...

7/23/2025Qilu Initiates Global Phase III Trial of QLS31905 for Pancreatic Cance...

7/23/2025DualityBio's DB‑1310 Earns FDA Fast‑Track for EGFR‑Mutated Lung Can...

7/23/2025SAMR Orders Simcere to Reverse Unnotified Merger Over Competition, Pri...

7/23/2025China-Singapore Nanovaccine Prevents Cancer Recurrence in Animals

7/23/2025Accelerating US Oncology Drug Development Using Chinese First-in-Human...

7/22/2025PharmaDJ's China Biopharma Tracker – June 2025 (PharmaDJ)

7/22/2025Chimigen Raises ~CNY 170M to Advance Cancer and HepB Vaccines

7/22/2025Innovent Secures IND for Oral GLP‑1 Agonist IBI3032 as Mazdutide Hits...

7/22/2025Huadong Subsidiary Reports Strong Phase III Results for Roflumilast Cr...

7/22/2025Lannacheng Secures Over CNY 300M in Series C+ to Advance Radiopharma P...

7/22/2025Suzhou Ribo Raises Over CNY 200M to Advance siRNA Therapeutics

7/22/2025Leads Biolabs' Hong Kong IPO Draws HK$220B in Overwhelming Demand

7/22/2025AusperBio Cleared to Begin Phase III Trial of AHB-137 for Chronic HepB...

Page:1/779 Total number of articles:23361: [First][<<] [1] [2] [3] [4] [5] [>>] [End]